Dr. Veraldi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3459 5th Ave
MUH 628 NW
Pittsburgh, PA 15213Phone+1 412-692-2118Fax+1 412-647-7875
Summary
- Dr. Kristen Veraldi is a pulmonologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian and VA Pittsburgh Healthcare System. She received her MD/PhD degree from University of Pittsburgh School of Medicine, Internal Medicine residency training at the University of Michigan, and Pulmonary Sciences and Critical Care Medicine fellowship training at the University of Colorado. She earned her executive MBA in Healthcare at the University of Pittsburgh Katz Graduate School of Business. She is board certified in both pulmonary and critical care medicine and is experienced in interstitial lung diseases.
Education & Training
- University of Pittsburgh Joseph M. Katz Graduate School of BusinessMBA in Healthcare, 2019 - 2020
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
- University of MichiganResidency, Internal Medicine, 2001 - 2004
- University of Pittsburgh School of MedicineClass of 2001, MD
- University of Pittsburgh School of MedicinePhD, Biochemistry, 1994 - 1999
Certifications & Licensure
- PA State Medical License 2007 - 2024
- CO State Medical License 2005 - 2009
- MI State Medical License 2001 - 2004
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2001 Oct 01
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2003 Jan 01
- Dorothy P. and Richard P. Simmons Center for ILD Research Registry Start of enrollment: 2003 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsExpression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.Jiangning Tan, John Tedrow, Justin A. Dutta, Brenda Juan-Guardela, Mehdi Nouraie
American Journal of Respiratory and Critical Care Medicine. 2016-12-01 - 50 citationsRespiratory bronchiolitis-interstitial lung disease: long-term outcome.Joshua Portnoy, Kristen L. Veraldi, Marvin I. Schwarz, Carlyne D. Cool, Douglas Curran-Everett
Chest. 2007-03-01 - 48 citationsLocalized expression of tenascin in systemic sclerosis–associated pulmonary fibrosis and its regulation by insulin‐like growth factor binding protein 3Monique L. Brissett, Kristen L. Veraldi, Joseph M. Pilewski, Thomas A. Medsger, Carol Feghali-Bostwick
Arthritis and Rheumatism. 2012-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: